PPARGC1A and metabolic syndrome: Women with PCOS exhibited significantly higher PPARGC1A promoter methylation and lower mtDNA content; PPARGC1A hypermethylation correlated with IR, waist circumference, and triglycerides. Lower mtDNA content was associated with increased metabolic risk. PCOS patients with metabolic syndrome had greater epigenetic alterations.